Model-Informed Drug Development (MIDD): A Data Driven Approach to End-to-End Drug Development
Angelean Hendrix
Drug development has always required decisions to be made in the face of uncertainty. Which dose should move forward? Which patient population is most appropriate? How should a study be designed to generate meaningful evidence? For many years, those decisions have been shaped through a largely empirical and sequential process—where decisions are made primarily based on the data generated in the previous step. While... The post Model-Informed Drug Development (MIDD): A Data Driven Approach to En